fbpx
SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

 

According to research presented at the recent 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), high dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates.  The Cyberknife at New Jersey Cyberknife delivers SBRT.  Although […]

 

Learn More

 

 

Screening Strategy May Predict Lethal Prostate Cancer Later in Life

 

A recent study found that mid-life prostate-specific antigen (PSA) levels predict who will be more likely to develop lethal prostate cancer.  Investigators from Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health found that measuring PSA levels in younger men (between the ages of 40 and 59) could accurately predict future […]

 

Learn More

 

 

Stereotactic Body Radiation Therapy Shows 98 Percent Prostate Cancer Cure

 

According to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center, a five-year study shows that stereotactic body radiation therapy (SBRT), which can be administered with the CyberKnife® Robotic Radiosurgery System, offers a higher cure rate for prostate cancer than more traditional approaches.  The study, the first trial to publish five-year results […]

 

Learn More

 

 

Prostate Cancer Predictors: An Overview of Findings from Recent Study

 

A 2015 study published in the journal Prostate shows prostate cancer incidence among distant relatives on both sides of a man’s family can help predict whether he will develop the disease.  According to study author Lisa Cannon-Albright, “Family history is a substantial risk factor for prostate cancer.  But typically, a clinician will ask a patient […]

 

Learn More

 

 

September is National Prostate Cancer Awareness Month

 

National Prostate Cancer Awareness Month is observed every September in the United States by health experts and advocates, and individuals concerned with men’s prostate health.  Designating a month for the disease serves the purpose of increasing public awareness of the importance of prostate health and screenings, educating about risk factors and symptoms, and advocating for […]

 

Learn More

 

 

The National Comprehensive Cancer Network® Supports SBRT for Prostate Cancer

 

The National Comprehensive Cancer Network recently updated their patient guide that supports stereotactic body radiation therapy (SBRT) for prostate cancer.  The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 26 of the world’s leading cancer centers, is dedicated to improving the quality, efficiency, and effectiveness of care for patients with cancer.   NCCN aims […]

 

Learn More

 

 

Prostate Cancer Patient Testimonial

 

 

Learn More

 

 

Wellpoint Anthem Updates Policy to Include Coverage of SBRT for Prostate Cancer

 

Wellpoint Anthem Blue Cross Blue Shield, the second largest commercial payer in the United States, recently announced that it has updated its SRS/SBRT policy to cover treatment for early stage prostate cancer. Stereotactic body radiation therapy, or SBRT, is a powerful, noninvasive treatment approach that targets radiation beams to match the size and shape of […]

 

Learn More

 

 

Men’s Health Month: A Closer Look at Prostate Cancer

 

June is Men’s Health Month. Celebrated each year to coincide with Father’s Day, this time is dedicated to raising awareness of health problems men may encounter through health education, fundraising and advocacy efforts promoting early detection and treatment of disease. Among the most prevalent men’s health issues is prostate cancer. The prostate is a walnut-shaped […]

 

Learn More

 

 

Prostate Cancer Treatment Update: 2014 NCCN Guidelines

 

The National Comprehensive Cancer Network® (NCCN) recently updated its NCCN Clinical Practice Guidelines in Oncology® to include stereotactic body radiation therapy (SBRT) as a treatment option for prostate cancer. SBRT for prostate cancer involves five or fewer treatment sessions, minimizing disruption to men’s normal routines and lifestyles. Read more about the NCCN and their updated […]

 

Learn More